Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Symbiotec Pharmalab Ltd

NSE: SYMBIOTEC · BSE: 544889 · Pharmaceuticals & Biotechnology · 7 announcements

Share price: ₹1,003.35
Market cap: ₹6,447 Cr
Revenue (annual): ₹869.1 Cr
Net profit (annual): ₹109.9 Cr
Promoter holding: 33.28%
FII holding: 21.08%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Share Pledge 1 Results Update 1 Financial Results 1 Capital Structure Change 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

21 Sep 2026 18:32 IST BSE

Financial Results

Symbiotec Pharmalab Q1 FY27 Results: Net Profit ₹14.1 Cr, Down 52.8% YoY

Symbiotec Pharmalab Ltd reported revenue from operations of ₹218.2 Cr (+7.4% YoY) and net profit of ₹14.1 Cr (-52.8% YoY) for Q1 FY27.

Key figure: Net profit ₹14.1 Cr · -52.8% YoY

Open full results → Read the filing ↗